HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feasibility and efficacy of an isocaloric high-protein vs. standard diet on insulin requirement, body weight and metabolic parameters in patients with type 2 diabetes on insulin therapy.

AbstractAIMS:
To determine the feasibility and efficacy of a high-protein diet compared with a standard diet aiming for weight maintenance in insulin treated type-2 diabetic patients on insulin requirement, body weight and metabolic parameters over 12 weeks.
METHODS:
In a randomized controlled trial we assigned 44 type-2 diabetic patients on insulin therapy either to high-protein or standard diet over 12 weeks. Parameters were evaluated at baseline and monthly.
RESULTS:
After 12 weeks, the high protein diet significantly decreased insulin requirement (9.4 ± 16.3 vs. +0.8 ± 4.8 IU, mean ± SD; p=0.007), fasting plasma glucose (41.7 ± 62.5 vs. 2.1 ± 39.0 mg dl(-1); p=0.02), body mass index (1.1 ± 0.8 vs. 0.3 ± 0.7 kg m(-2); p=0.003), fat-free (0.8 ± 0.5 vs. 0.2 ± 0.5 kg; p=0.001), fat mass (2.6 ± 1.7 vs. 0.8 ± 1.6 kg; p=0.001) and increased serum folate (4.2 ± 8.3 vs. − 0.8 ± 5.5 nmol l(-1); p=0.04) compared to the standard diet. These beneficial metabolic effects are most likely related to the achieved weight loss. No significant differences between groups in renal function were observed.
CONCLUSIONS:
In this study we demonstrate that a high protein diet with emphasis on plant source protein vs. a standard diet is feasible in insulin-treated type-2 diabetic patients and reduces insulin requirement and body weight and improves metabolic parameters up to 12 weeks. A high protein diet can thus be considered as an appropriate diet choice for type-2 diabetic patients.
AuthorsM Luger, B Holstein, K Schindler, R Kruschitz, B Ludvik
JournalExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (Exp Clin Endocrinol Diabetes) Vol. 121 Issue 5 Pg. 286-94 (May 2013) ISSN: 1439-3646 [Electronic] Germany
PMID23674159 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Blood Glucose
  • Dietary Proteins
  • Hypoglycemic Agents
  • Insulin
Topics
  • Aged
  • Blood Glucose (drug effects, metabolism)
  • Body Composition (drug effects)
  • Body Weight (drug effects)
  • Carbohydrate Metabolism (drug effects)
  • Diabetes Mellitus, Type 2 (complications, diet therapy, drug therapy, metabolism)
  • Dietary Proteins (pharmacology, therapeutic use)
  • Energy Intake (physiology)
  • Feasibility Studies
  • Female
  • Humans
  • Hypoglycemic Agents (administration & dosage)
  • Insulin (administration & dosage)
  • Male
  • Middle Aged
  • Obesity (complications, diet therapy, metabolism)
  • Patient Compliance
  • Recommended Dietary Allowances
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: